Education
About Us
Working with TipRanks
Follow Us
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.53M | $ 1.56M | $ 1.36M | $ 285.00K | $ 0.00 |
| Gross Profit | $ 1.53M | $ 1.56M | $ 296.00K | $ -716.00K | $ -95.00K |
| Operating Income | $ -96.35M | $ -67.12M | $ -56.31M | $ -43.62M | $ -22.21M |
| EBITDA | $ -96.35M | $ -65.25M | $ -53.92M | $ -42.61M | $ -22.11M |
| Net Income | $ -93.44M | $ -62.68M | $ -55.28M | $ -42.41M | $ -22.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 40.58M | $ 102.75M | $ 97.89M | $ 45.75M | $ 74.59M |
| Total Assets | $ 66.35M | $ 142.60M | $ 109.97M | $ 54.87M | $ 80.83M |
| Total Debt | $ 34.38M | $ 26.88M | $ 2.22M | $ 1.45M | $ 2.44M |
| Net Debt | $ -6.20M | $ 4.53M | $ -30.33M | $ -44.29M | $ -72.15M |
| Total Liabilities | $ 54.75M | $ 53.18M | $ 29.21M | $ 20.55M | $ 6.34M |
| Stockholders' Equity | $ 11.59M | $ 89.42M | $ 80.75M | $ 34.32M | $ 74.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.35M | $ -64.35M | $ -43.55M | $ -29.20M | $ -22.92M |
| Operating Cash Flow | $ -70.01M | $ -63.30M | $ -43.38M | $ -25.82M | $ -21.14M |
| Investing Cash Flow | $ 80.31M | $ -12.58M | $ -65.01M | $ -3.38M | $ -1.77M |
| Financing Cash Flow | $ 8.53M | $ 65.69M | $ 96.26M | $ 359.00K | $ 87.70M |